Cart
sales@molnova.com
Fibrinopeptide B, human TFA
CAS No. ———
Fibrinopeptide B, human TFA( ——— )
Catalog No. M40550 CAS No. ———
FibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFibrinopeptide B, human TFA
-
NoteResearch use only, not for human use.
-
Brief DescriptionFibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.
-
DescriptionFibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
36-Dihydroxyflavone
36-Dihydroxyflavone?suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway.
-
PKR-IN-C16
PKR-IN-C16 is a specific protein kinase (PKR) inhibitor.?PKR-IN-C16 is able to inhibit the autophosphorylation of PKR and unlock the translation blockade induced by PKR in primary neuronal cultures.PKR-IN-C16 binds the ATP-binding site of PKR and blocks autophosphorylation with an IC50 value of 186-210 nM.?
-
SBE-β-CD
SBE-β-CD is a sulfobutylether β-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
